Current status of cell therapy for systemic arterial hypertension

References

• Cooper RS, Tayo B. Geographic patterns of hypertension: a global perspective. In: Hypertension Primer: The Essentials of High Blood Pressure. 4th Edition. Izzo, JL, Sica DA, Black HR (Eds). Lippincott, Williams and Wilkins, PA, USA, 239–241 (2008).
   Google Scholar
• Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension42(6), 1206–1252 (2003).
   PubMed Web of Science ®Google Scholar
• Pravenec M, Kurtz TW. Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies. Hypertension49(5), 941–952 (2007).
   PubMedGoogle Scholar
• Coleman TG, Hall JE. Systemic hemodynamics and regional blood flow regulation. In: Hypertension Primer: The Essentials of High Blood Pressure. 4th Edition. Izzo, JL, Sica DA, Black HR (Eds). Lippincott, Williams and Wilkins, PA, USA, 129–132 (2008).
   Google Scholar
• Judy WV. Watanabe AM. Henry DP et al. Sympathetic nerve activity: role in regulation of blood pressure in the spontaneously hypertensive rat. Circ. Res.38(Suppl. 2), 21–29 (1976).
   PubMed Web of Science ®Google Scholar
• Brooks VL, Haywood JR, Johnson AK. Translation of salt retention to central activation of the sympathetic nervous system in hypertension. Clin. Exp. Pharmacol. Physiol.32(5–6), 426–432 (2005).
   PubMedGoogle Scholar
• McIntyre M, Bohr DF, Dominiczak AF. Endothelial function in hypertension: the role of superoxide anion. Hypertension34, 539–545 (1999).
   PubMed Web of Science ®Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension44, 248–252 (2004).
   PubMed Web of Science ®Google Scholar
• Levy BI, Ambrosio G, Pries AR et al. Microcirculation in hypertension: a new target for treatment? Circulation104, 735–740 (2001).
   PubMed Web of Science ®Google Scholar
• le Noble FA, Stassen FR, Hacking WJ et al. Angiogenesis and hypertension. J. Hypertens.16, 1563–1572 (1998).
   PubMed Web of Science ®Google Scholar
• Wang H, Olszewski, B, Rosebury W et al. Impaired angiogenesis in SHR is associated with decreased KDR and MT1-MMP expression. Biochem. Biophys. Res. Comm.315, 363–368 (2004).
   PubMedGoogle Scholar
• Murasawa S, Asahara T. Endothelial progenitor cells for vasculogenesis. Physiology (Bethesda)20, 36–42 (2005).
   PubMed Web of Science ®Google Scholar
• Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science275(5302), 964–967 (1997).
   PubMed Web of Science ®Google Scholar
• Shi Q, Rafii S, Wu MH et al. Evidence for circulating bone marrow-derived endothelial cells. Blood92(2), 362–367 (1998).
   PubMed Web of Science ®Google Scholar
• Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood95, 952–958 (2000).
   PubMed Web of Science ®Google Scholar
• Vasa M, Fichtlscherer S, Aicher A et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res.89, E1–E7, (2001).
   PubMed Web of Science ®Google Scholar
• Imanishi T, Moriwaki C, Hano T et al. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J. Hypertens.23(10), 1831–1837 (2005).
   PubMed Web of Science ®Google Scholar
• Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med.353(10), 999–1007 (2005).
   PubMed Web of Science ®Google Scholar
• Pirro M, Schillaci G, Menecali C et al. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J. Hypertens.25(10), 2093–2099 (2007).
   PubMed Web of Science ®Google Scholar
• Oliveras A, Soler MJ, Martínez-Estrada OM et al. Endothelial progenitor cells are reduced in refractory hypertension. J. Hum. Hypertens.22(3), 183–190 (2008).
   PubMed Web of Science ®Google Scholar
• Umemura T, Soga J, Hidaka T et al. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am. J. Hypertens.21(11), 1203–1209 (2008).
   PubMed Web of Science ®Google Scholar
• Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J. Hypertens.23(1), 97–104 (2005).
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Zeiher AM, Schneider MD. Unchain my heart: the scientific foundations of cardiac repair. J. Clin. Invest.115(3), 572–583 (2005).
   PubMed Web of Science ®Google Scholar
• Kukharchuk OL, Radchenko VV, Sipman BM et al. Effect of allotransplantation of embryonic pluripotent progenitor cells on dynamics of systemic arterial blood pressure in spontaneously hypertensive rats. Fiziol. Zh.49, 68–71 (2003).
   Google Scholar
• Nagaya N, Kangawa K, Kanda M et al. Hybrid cell-gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells. Circulation108, 889–895 (2003).
   PubMed Web of Science ®Google Scholar
• Marsboom G, Janssens S. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies. Expert Rev. Cardiovasc. Ther.6(5), 687–701 (2008).
   PubMedGoogle Scholar
• Wassmann S, Werner N, Czech T et al. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ. Res.99(8), e74–e83 (2006).
   PubMed Web of Science ®Google Scholar
• Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res.103(11), 1204–1219 (2008).
   PubMed Web of Science ®Google Scholar
• Watson T, Goon PK, Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid. Redox Signal.10(6), 1079–1088 (2008).
   PubMed Web of Science ®Google Scholar
• de Nigris F, Balestrieri ML, Williams-Ignarro S et al. Therapeutic effects of autologous bone marrow cells and metabolic intervention in the ischemic hindlimb of spontaneously hypertensive rats involve reduced cell senescence and CXCR4/Akt/eNOS pathways. J. Cardiovasc. Pharmacol.50(4), 424–433 (2007).
   PubMedGoogle Scholar
• Chade AR, Zhu X, Lavi R et al. Endothelial progenitor cells restore renal function in chronic experimental renovascular disease. Circulation119(4), 547–557 (2009).
   PubMed Web of Science ®Google Scholar
• de Macedo Braga LM, Lacchini S, Schaan BD et al. In situ delivery of bone marrow cells and mesenchymal stem cells improves cardiovascular function in hypertensive rats submitted to myocardial infarction. J. Biomed. Sci.15(3), 365–374 (2008).
   PubMedGoogle Scholar
• Braga LM, Rosa K, Rodrigues B et al. Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol.35(2), 113–119 (2008).
   PubMed Web of Science ®Google Scholar
• Perry TE, Song M, Despres DJ et al. Bone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunction. Cardiovasc. Res. DOI: 10.1093/cvr/cvp215 (2009) (Epub ahead of print).
   PubMedGoogle Scholar
• Aicher A, Heeschen C, Mildner-Rihm C et al. Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med.9(11), 1370–1376 (2003).
   PubMed Web of Science ®Google Scholar
• Dias da Silva VJ, Machado MP, Rocha AM et al. Bone marrow stem/progenitor cells reduce arterial blood pressure and ameliorate endothelial dysfunction in spontaneously hypertensive rats. FASEB J. (Abstract) 19, 7439–7439 (2005).
   Google Scholar